Sodium Polystyrene Sulfonate

聚磺苯乙烯钠

Report date: 2023/02/21 16:48:44
NME

Base Information

Drug NameSodium Polystyrene Sulfonate
Drug Alias NameSodium Polystyrene Sulphonate聚乙烯磺酸钠聚对苯乙烯磺酸钠Kayexalate聚苯乙烯磺酸钠 +[7] 
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHyperkalemia
Global Approved IndicationsHyperkalemia
Approved Indications in ChinaHyperkalemia
Original Approved Country/TerritoryUnited States
Original Approved Date1958/06/05
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesConcordia
China Registration ClassN/A

Develop Information

Active CompaniesTorii Pharmaceutical Co LtdShanghai Shikangte Pharmaceutical Co Ltd
Inactive CompaniesConcordia Pharmaceuticals Inc
Active IndicationsHyperkalemia
Inactive IndicationsN/A

Other Information

ATC CodeV03AE01
Related LinksWikipediaDrugBankKEGG